Use of CXCR2 Antagonists For The Prevention and/or Treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN)
US-2017224679-A1 · Aug 10, 2017 · US
US10214488B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10214488-B2 |
| Application number | US-201715624815-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 16, 2017 |
| Priority date | Jun 21, 2016 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are methods and/or systems to convert sulfide intermediates to sulfilimines using a series of continuous loop reactors instead of a batch reactor. The advantages of the methods and systems provided include improved total yield, improved heat management, improved phase mixing, and/or improved volume management.
Opening claim text (preview).
We claim: 1. A method of preparing a sulfilimine of Formula (I), wherein X represents halogen, C 1 -C 4 alkyl or C 1 -C 4 haloalkyl; comprising, (a) mixing a solution cyanamide, a solution of hypochlorite, and a solvent in a first continuous loop reactor; (b) transferring the mixture of Step (a) into a second continuous loop reactor; (c) adding a sulfide of Formula (II) into the second continuous loop reactor which reacts with the mixture of Step (a) to form the sulfilimine, wherein X is as previously defined; and (d) decanting the aqueous phase giving an organic phase containing a sulfilimine of Formula (I). 2. The method of claim 1 , wherein X represents CF 3 . 3. The method of claim 1 , wherein the solvent comprises acetonitrile. 4. The method of claim 1 , wherein Step (a) is performed at a temperature between −9° C. and 5° C. 5. The method of claim 1 , wherein Step (a) is performed at a temperature between −5° C. and −3° C. 6. The method of claim 1 , wherein Step (c) is performed at a temperature between −13° C. and 3° C. 7. The method of claim 1 , wherein Step (c) is performed at a temperature between −5° C. and −3° C. 8. The method of claim 1 , wherein the cyanamide/hypochlorite mole ratio is between 1.0 and 2.0, the hypochlorite/sulfide mole ratio is between 1.0 and 2.5, and/or the acetonitrile solvent/sulfide mass ratio is about between 1.5 and 5. 9. The method of claim 1 , wherein the cyanamide/hypochlorite mole ratio is between 1.15 and 1.4, the hypochlorite/sulfide mole ratio is between 1.2 and 1.5, and/or the acetonitrile solvent/sulfide mass ratio is about between 2.5 and 3.
Nitriles · CPC title
controlling the pH · CPC title
Plates; Jackets; Cylinders · CPC title
in series · CPC title
to which a second hetero atom is attached · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.